This announcement is a separate document:
自愿披露关于HP560片用于治疗骨髓纤维化（骨髓增殖性肿瘤）的临床试验获得药物临床试验批准通知书的公告
Announcement of voluntary disclosure of clinical trial approval notice for drug clinical trial of HP560 tablets used for the treatment of myelofibrosis (myeloproliferative tumor)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated